Shares of ClearPoint Neuro Inc. (CLPT) touched a new 52-week high of $10.84 yesterday, driven by recent strong quarterly results and an upgraded annual forecast, which has captured investors' attention.
ClearPoint Neuro is a global device, cell, and gene therapy-enabling company comprised of two parts: (i) a business providing medical devices for neurosurgical applications, and (ii) a business focused on partnerships in the biologics and drug delivery space.
Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe NowAlready subscribed? Sign in
For comments and feedback: editorial@rttnews.com